Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Transposagen Biophamaceuticals

Transposagen Biophamaceuticals
2003 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$4.3M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of animal models, cell lines, stem cells, research tools and technologies to improve drug discovery and development research. The company is biotechnology based and provides genetically modified rat models to pharmaceutical and biotechnology companies, academic laboratories and the National Institutes of Health.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 535 West Second Street
  • Suite L102
  • Lexington, KY 40508
  • United States

+1 (859) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Transposagen Biophamaceuticals’s full profile, request a free trial.

Transposagen Biophamaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 21-Jun-2013 $4.3M 00.000 Completed Generating Revenue
3. Angel (individual) 18-Jul-2012 00000 00.000 Completed Generating Revenue
2. Angel (individual) 20-Dec-2011 $725K $725K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Transposagen Biophamaceuticals Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Caribou Biosciences Venture Capital-Backed Berkeley, CA 00 000.00 00000000000 000.00
0000000 Corporation Seoul, South Korea 00
000000 00000000000 Formerly VC-backed Zug, Switzerland 000 00000 00000000000 00000
00000000 Venture Capital-Backed Redwood City, CA 00 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Menlo Park, CA 000 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Transposagen Biophamaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0

Transposagen Biophamaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Eric Ostertag Ph.D Chief Executive Officer & President

Transposagen Biophamaceuticals Board Members (1)

Name Representing Role Since Contact
Info
Nishan Silva MD Self Board Member 000 0000